Literature DB >> 2874053

Arginine vasopressin as a central neurotransmitter.

C L Riphagen, Q J Pittman.   

Abstract

Anatomical and electrophysiological studies have revealed a widespread innervation of the brain by arginine vasopressin (AVP)-containing fibers. There is evidence that these central AVP pathways may be activated simultaneously with endocrine pathways. Stimulation of hypothalamic nuclei that contain AVP cell bodies causes changes in electrical activity of neurons in areas receiving AVP projections; in these same regions, release of immunoreactive AVP can be detected in response to appropriate stimuli or hypothalamic stimulation. These parts of the brain have also been shown to contain AVP receptors, and application of AVP to cells in these areas alters spontaneous activity or modifies the responses to other transmitters. AVP appears to act as a neurotransmitter involved in the central control of the cardiovascular, renal, and thermoregulatory systems. AVP may act centrally to coordinate autonomic and endocrine responses to homeostatic perturbations.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2874053

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  7 in total

1.  Role of spinal V1a receptors in regulation of arterial pressure during acute and chronic osmotic stress.

Authors:  Britta Veitenheimer; John W Osborn
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-12-01       Impact factor: 3.619

2.  Effect of small molecule vasopressin V1a and V2 receptor antagonists on brain edema formation and secondary brain damage following traumatic brain injury in mice.

Authors:  Sandro M Krieg; Sebastian Sonanini; Nikolaus Plesnila; Raimund Trabold
Journal:  J Neurotrauma       Date:  2014-12-16       Impact factor: 5.269

3.  Effects of intrathecal kynurenate on arterial pressure during chronic osmotic stress in conscious rats.

Authors:  Britta Veitenheimer; John W Osborn
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-11-16       Impact factor: 4.733

4.  Perinatal exposure to organohalogen pollutants decreases vasopressin content and its mRNA expression in magnocellular neuroendocrine cells activated by osmotic stress in adult rats.

Authors:  Samuel Mucio-Ramírez; Eduardo Sánchez-Islas; Edith Sánchez-Jaramillo; Margarita Currás-Collazo; Victor R Juárez-González; Mhar Y Álvarez-González; L E Orser; Borin Hou; Francisco Pellicer; Prasada Rao S Kodavanti; Martha León-Olea
Journal:  Toxicol Appl Pharmacol       Date:  2017-06-01       Impact factor: 4.219

5.  Effects of vasopressin and angiotensin II on neurones in the rat dorsal motor nucleus of the vagus, in vitro.

Authors:  Z L Mo; T Katafuchi; H Muratani; T Hori
Journal:  J Physiol       Date:  1992-12       Impact factor: 5.182

6.  Stimulation of vasopressin release in the ventral septum of the rat brain suppresses prostaglandin E1 fever.

Authors:  A M Naylor; Q J Pittman; W L Veale
Journal:  J Physiol       Date:  1988-05       Impact factor: 5.182

7.  Arginine-vasopressin V1 but not V2 receptor antagonism modulates infarct volume, brain water content, and aquaporin-4 expression following experimental stroke.

Authors:  Xiaoqin Liu; Shin Nakayama; Mahmood Amiry-Moghaddam; Ole Petter Ottersen; Anish Bhardwaj
Journal:  Neurocrit Care       Date:  2010-02       Impact factor: 3.210

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.